Skandinaviska Enskilda Banken (SEB)
ATRA icon

Skandinaviska Enskilda Banken (SEB)’s Atara Biotherapeutics ATRA Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,446
Closed -$519K – 1050
2021
Q1 		$519K Buy
+1,446
New +$639K ﹤0.01% 927
2020
Q4 		– Sell
-1,446
Closed -$469K – 1130
2020
Q3 		$469K Buy
+1,446
New +$492K ﹤0.01% 835
2019
Q4 		– Sell
-1,446
Closed -$511K – 927
2019
Q3 		$511K Buy
+1,446
New +$540K ﹤0.01% 787

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s ATRA Position: Q2 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Atara Biotherapeutics (ATRA) in Q2 2021, closing a stake of 1,446 shares — an estimated $519K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ATRA in Q3 2019 and held it in 3 quarters. The position peaked at $519K in Q1 2021. 145 funds tracked by Wall St. Rank hold ATRA as of Q2 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Atara Biotherapeutics position as of Q2 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 1,446 Atara Biotherapeutics shares in Q2 2021, an estimated $519K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Atara Biotherapeutics in Q3 2019 and held it in 3 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Atara Biotherapeutics position peaked at $519K in Q1 2021.
  • 145 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2021, filed 10 Aug 2021.